To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
119th Congress
Introduced May 20, 2025
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
May 20, 2025
Mr. Sanders (for himself, Mr. Blumenthal, Mr. Booker, Mr. Merkley, …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology